Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma

Trial Profile

Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 08 Jan 2016 Planned End Date changed from 1 Jan 2015 to 1 Jan 2018 as reported by ClinicalTrials.gov.
    • 08 Jan 2016 Planned primary completion date changed from 1 Jan 2015 to 1 Jan 2018 as reported by ClinicalTrials.gov.
    • 21 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top